Appendix cancer differential diagnosis: Difference between revisions

Jump to navigation Jump to search
No edit summary
 
(110 intermediate revisions by 3 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
'''For the WikiDoc page for this topic, click [[Appendix cancer|here]]'''
 
[[Image:Home_logo1.png|right|250px|link=https://www.wikidoc.org/index.php/Appendix_cancer]]


{{CMG}}; {{AE}} {{Soroush}}
{{CMG}}; {{AE}} {{Soroush}}


==Overview==
==Overview==
Appendix cancer must be differentiated from benign appendix lesions (mucocele, acute appendicitis), colorectal cancers, adenexal masses (ovarian tumors), and carcinoid tumors of the other organs.
[[Vermiform appendix|Appendix]] [[cancer]] must be [[Appendix cancer differential diagnosis|differentiated]] from [[Benign|benign appendix lesions]] ([[mucocele]], [[Appendicitis|acute appendicitis]]), [[Colorectal cancer|colorectal cancers]], [[Ovarian cancer|adenexal masses]] ([[Ovarian cancer|ovarian tumors]]), and [[Neuroendocrine tumors|carcinoid tumors of the other organs]].


==Differentiating appendix cancer from other Diseases==
==Differentiating appendix cancer from other Diseases==
*Appendix cancer must be differentiated from benign appendix lesions (mucocele, acute appendicitis), colorectal cancers, adenexal masses (ovarian tumors), and carcinoid tumors of the other organs.  
*[[Vermiform appendix|Appendix]] [[cancer]] must be [[Appendix cancer differential diagnosis|differentiated]] from [[Benign|benign appendix lesions]] ([[mucocele]], [[Appendicitis|acute appendicitis]]), [[Colorectal cancer|colorectal cancers]], [[Ovarian cancer|adenexal masses]] ([[Ovarian cancer|ovarian tumors]]), and [[Neuroendocrine tumors|carcinoid tumors of the other organs]].  
*As appendix cancer manifests in a variety of clinical forms, differentiation must be established in accordance with the particular subtype.  
*As [[appendix cancer]] manifests in a variety of [[clinical]] forms, differentiation must be established in accordance with the particular subtype.  
:*Carcinoid tumors must be differentiated from other diseases that causecarcinoid syndrome, such as palpitation, facial flushing, diarrhea, .  
:*[[Carcinoid Tumor|Carcinoid tumors]] must be differentiated from other diseases that cause [[carcinoid syndrome]] sign and symptoms such as [[palpitation]], [[Flushing|facial flushing]], and [[diarrhea]].  
:*In contrast, adenocarcinomas and cystadenocarcinomas must be differentiated from other diseases that cause acute appendicitis or present with pseudomyxoma peritonei, such as colorectal cancers, appendix mucoceles.
:*In contrast, [[adenocarcinoma]]<nowiki/>s and cystadenocarcinomas must be differentiated from other diseases that cause [[Appendicitis|acute appendicitis]] or present with [[pseudomyxoma peritonei]], such as [[Colorectal cancer|colorectal cancers]] and [[Appendix cancer echocardiography and ultrasound|appendix mucoceles]].
 
<small>
{| class="wikitable"
{| class="wikitable"
|-  
|-  
! colspan="2" rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;"|Diseases
! colspan="2" rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diseases
| colspan="7" rowspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Clinical manifestations'''
| colspan="7" rowspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Clinical manifestations'''
! colspan="7" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Para-clinical findings
! colspan="7" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Para-clinical findings
| colspan="1" rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Gold standard'''
|-
|-
| colspan="4" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Symptoms'''
| colspan="4" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Symptoms'''
Line 25: Line 25:
! colspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Lab Findings
! colspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Lab Findings
! colspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Imaging
! colspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Imaging
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Histopathology
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Histo-
pathology
|-  
|-  
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Abdominal pain'''
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Abdo-<br>minal<br>pain'''
! colspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Change in girdle size
! colspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Change in girdle size
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Change in bowel habits
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Bowel
! colspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |  '''Other symptoms'''
freq-
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Abdominal mass
 
! colspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |abdominal tenderness
uency
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other physical examination findings
! colspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |  '''Other'''
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Urinary 5-hydroxyindoleacetic acid (5-HIAA) and/or Serum Chromogranin A (CgA)'''
'''symptoms'''
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Abdo-<br>minal<br> mass
! colspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Abdo-<br>minal<br> tender-<br>ness
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other
physical  
 
exami-
 
nation
 
findings
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''5-HIAA<br>and/or<br>CgA'''
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other lab findings
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other lab findings
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |CT scan
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |CT scan
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |MRI
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |MRI
! colspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Utrasounography
! colspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Utra-
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other diagnostic studies and imaging modalities
sounography
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other
diagnostic
 
studies
 
and
 
imaging
 
modalities
|-
|-
| rowspan="3" style="background: #DCDCDC; padding: 5px; text-align: center;" |Appendix cancer
| rowspan="3" style="background: #DCDCDC; padding: 5px; text-align: center;" |Appendix cancer
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Adenocarcinoma<small><sup>1</sup></small>
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Adenocarcinoma|Adeno-]]
[[Adenocarcinoma|carcinoma]]<small><sup>1</sup></small>
| style="background: #F5F5F5; padding: 5px;" | +/-
| style="background: #F5F5F5; padding: 5px;" | +/-
| style="background: #F5F5F5; padding: 5px;" | -/+
| style="background: #F5F5F5; padding: 5px;" | -/+
| style="background: #F5F5F5; padding: 5px;" | Constipation
| style="background: #F5F5F5; padding: 5px;" | <math>\downarrow</math>
| rowspan="1" style="background: #F5F5F5; padding: 5px;" |
| rowspan="1" style="background: #F5F5F5; padding: 5px;" |
* '''Generally asymptomatic'''  
* '''Generally [[Asymptomatic|asympto-<br>matic]]'''  
* Appendicitis symptoms  
* [[Appendicitis]] [[Symptom|symptoms]]
* [[Nausea and vomiting|Nausea & vomiting]],[[decreased appetite]] (anorexia)
* [[Nausea and vomiting|Nausea<br>&<br>vomiting]],<br>decreased<br>[[appetite]]
* No gas or stool pass (intestinal obstruction)  
* No gas<br>or<br>stool pass<br>([[Bowel obstruction|intestinal<br>obstruction]])  
* Bone pain (bone metastasis)  
* [[Bone pain]]<br>(bone<br>[[Metastasis|metastasis)]]
* Bloating (ascites)  
* [[Bloating]]<br>([[ascites]])  
| style="background: #F5F5F5; padding: 5px;" | -  
| style="background: #F5F5F5; padding: 5px;" | -  
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* [[Ascites]]  
* [[Ascites]]  
* Shifting dullness  
* [[Shifting             dullness]]


| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* CEA  
* [[CEA]]
* CA 19-9  
* [[CA 19-9]]
*   
*   
| rowspan="2" style="background: #F5F5F5; padding: 5px;" |
| rowspan="2" style="background: #F5F5F5; padding: 5px;" |
* Soft tissue thickening
* Soft<br>tissue<br>thickening
* Wall irregularity
* Wall<br> irregularity
* Presence of pseudomyxoma peritonei
* Presence<br>of<br> [[Pseudomyxoma peritonei|pseudo-<br>myxoma<br>peritonei]]
* Calcification
* [[Calcification]]
* Internal septations
* Internal<br>septations
* Periappendiceal fat stranding and intraperitoneal free fluid which is a nonspecific finding
* Peri<br>appendiceal<br>fat<br>stranding<br>and<br>intra-<br>peritoneal<br>free fluid<br> which is a<br> nonspecific<br> finding
* Cystic lesion
* Cystic<br> lesion
*  
*  
| rowspan="2" style="background: #F5F5F5; padding: 5px;" |
| rowspan="2" style="background: #F5F5F5; padding: 5px;" |
* Diffusion weighted MRI has been shown to be the modality of choice for peritoneal carcinomatosis
* Diffusion<br>weighted<br>[[Magnetic resonance imaging|MRI]]<br>has<br>been<br>shown to<br>be<br>the<br>modality<br>of choice<br>for<br>''[[Peritoneal carcinomatosis|peritoneal<br>carcino-<br>matosis]]''
* Increased fluid signal on T2 weighted sequence
* Increased<br>fluid<br>signal on<br>T2 weighted sequence
* Soft tissue mass in the [[appendix]]
* Soft<br> tissue<br> mass in<br> the<br>[[appendix]]
* Invasion to other structures
* Invasion to<br>the other<br>structures
| rowspan="2" style="background: #F5F5F5; padding: 5px;" |
| rowspan="2" style="background: #F5F5F5; padding: 5px;" |
* Dilated appendix
* Dilated<br>appendix
* Periappendiceal fluid collection
* Peri-<br>appendiceal<br> fluid<br> collection
* Distinct appendix wall layers
* Distinct<br> appendix<br> wall<br> layers
| style="background: #F5F5F5; padding: 5px;" |[[Positron emission tomography]] (PET)
| style="background: #F5F5F5; padding: 5px;" |[[Positron emission tomography|Positron<br>emission<br>tomography]]<br>(PET)
| style="background: #F5F5F5; padding: 5px;" |'''Gross pathology''':
| style="background: #F5F5F5; padding: 5px;" |'''Gross<br>[[pathology]]''':
* Gray/yellow color
* Gray/yellow<br>color


* Cystic structures with angiolymphatic invasion
* Cystic<br>structures<br>with<br>angiolymphatic<br>invasion
* Appendix might be buried within the mass
* [[Vermiform appendix|Appendix]]<br>might be<br>buried<br>within<br>the mass
'''Microscopic pathology:'''
'''Microscopic<br>pathology:'''
* Intestinal, mucinous or signet ring cell types
* Intestinal,<br>mucinous<br>or<br>[[Signet ring cell carcinoma|signet ring<br>cell]] types
* Coexisting acute appendicitis is common
* Coexisting<br>[[Appendicitis|acute<br>appendicitis]]<br>is common
'''IHC''' might be positive for the following '''stains:'''
'''[[Immunohistochemistry|IHC]]:'''
* MUC 2  
* MUC 2  
* '''MUC5AC'''  
* '''MUC5AC'''  
Line 98: Line 121:
* CK 19
* CK 19
* CK 20
* CK 20
| style="background: #F5F5F5; padding: 5px;" |[[Biopsy]]
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Carcinoid tumor<sup>2</sup>
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Carcinoid Tumor|Carcinoid]]
[[Carcinoid Tumor|tumor]]<sup>2</sup>
| style="background: #F5F5F5; padding: 5px;" | +/-
| style="background: #F5F5F5; padding: 5px;" | +/-
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | Diarrhea
| style="background: #F5F5F5; padding: 5px;" | <math>\uparrow</math>
| rowspan="1" style="background: #F5F5F5; padding: 5px;" |
| rowspan="1" style="background: #F5F5F5; padding: 5px;" |
* '''Generally asymptomatic'''  
* '''Generally [[Asymptomatic|asympto-<br>matic]]'''
* Flushing  
* [[Flushing]]
* Palpitation  
* [[Palpitation]]
* Dyspnea  
* [[Dyspnea]]
*   
*   
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Tricuspid regurgitation
* [[Tricuspid regurgitation|TR]]<br>[[Heart murmur|murmur]]
* murmur
* [[Wheeze|Wheezing]]
* Wheezing
| style="background: #F5F5F5; padding: 5px;" | +
| style="background: #F5F5F5; padding: 5px;" | +
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Ki67: a reliable marker of cell proliferation  
Ki67:<br>a reliable<br>marker of<br>cell<br>proliferation  
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* [[Somatostatin]] [[scintigraphy]] with 111-indium-octreotide
* [[Somatostatin]]<br>[[scintigraphy]]<br>with<br> 111-indium-<br>octreotide
* [[Bone]] [[scintigraphy]] with 99mTc-methylene diphosphonate (99mTcMDP)
* [[Bone]]<br>[[scintigraphy]]<br> with<br> 99mTc-<br>methylene<br> diphosphonate<br>(99mTcMDP)
* [[Positron emission tomography]] (PET)
* Positron<br>emission<br>tomography<br>(PET)
| style="background: #F5F5F5; padding: 5px;" |'''Gross pathology''':
| style="background: #F5F5F5; padding: 5px;" |'''Gross<br>[[pathology]]''':
** Prevalent at the tip of appendix
* [[Prevalence|Prevalent]]<br>at the<br>tip of<br>[[Vermiform appendix|appendix]]
** Generally less than 1 cm
* Generally<br>less than<br>1 cm
** Gray or yellow
* Gray or <br>yellow
** Well-demarcated firm
* Well-<br>demarcated<br>firm
** Intramural nodules that may narrow or obliterate appendiceal lumen
* Intramural<br>nodules<br>that may<br>narrow or<br>obliterate<br>appendiceal<br> lumen
** Proximal tumors may cause obstruction and appendicitis
* Proximal<br>tumors<br>may cause<br>obstruction<br>and<br>appendicitis
'''Microscopic pathology:'''
'''Microscopic<br>pathology:'''


*Insular growth pattern of solid islands of uniform polygonal cells with minimal pleomorphism
*Insular<br>growth<br>pattern<br>of solid<br>islands of<br>uniform<br>polygonal<br>cells with<br>minimal<br>pleomorphism


*Retraction of peripheral tumor cells from stroma
*Retraction<br>of<br>peripheral<br>tumor<br>cells from<br> stroma


*Angiolymphatic invasion is common
*Angio-<br>lymphatic<br>invasion<br>is common


*Granular eosinophilic cytoplasm with either diffusely scattered or peripherally clumped granules
*Granular<br>eosinophilic<br>cytoplasm<br>with either<br>diffusely<br>scattered<br>or<br>peripherally<br>clumped<br>granules


*Two types of well differentiated tumors: EC cell (serotonin producing) and rarely L-cell (enteroglucagon or peptide YY producing)
*Two types<br>of well<br>differentiated<br>tumors:<br> EC cell <br>(serotonin<br> producing) <br>and rarely<br> L-cell<br> (enteroglucagon<br>or <br>peptide YY <br>producing)


'''IHC''' might be positive for '''S100'''
[[Immunohistochemistry|'''IHC''']]''':'''
*Might be<br> positive for <br>'''S100'''
|-
| style="background: #DCDCDC; padding: 5px;" |Goblet
cell


| style="background: #F5F5F5; padding: 5px;" | [[Biopsy]]
carcinoid
|-
| style="background: #DCDCDC; padding: 5px;" |Goblet cell carcinoid
| style="background: #F5F5F5; padding: 5px;" | +
| style="background: #F5F5F5; padding: 5px;" | +
| style="background: #F5F5F5; padding: 5px;" | +/-
| style="background: #F5F5F5; padding: 5px;" | +/-
| style="background: #F5F5F5; padding: 5px;" | +
| style="background: #F5F5F5; padding: 5px;" | <math>\uparrow</math>
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* '''Generally asymptomatic'''  
* '''Generally asympto-<br>matic'''  
* 60% present with [[acute appendicitis]] symptoms  
* 60% present<br>with [[acute appendicitis]] symptoms  
* [[Nausea and vomiting|Nausea & vomiting]],[[decreased appetite]] (anorexia)
* [[Nausea and vomiting|Nausea<br>&<br>vomiting]]
* [[decreased appetite]]<br>(anorexia)
| style="background: #F5F5F5; padding: 5px;" | +/-
| style="background: #F5F5F5; padding: 5px;" | +/-
| style="background: #F5F5F5; padding: 5px;" | +
| style="background: #F5F5F5; padding: 5px;" | +
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* [[Ascites]]  
* [[Ascites]]  
* Shifting dullness  
* Shifting<br>dullness  
* May appear anemic  
* May<br>appear<br>anemic  
*   
*   
| style="background: #F5F5F5; padding: 5px;" | +/-
| style="background: #F5F5F5; padding: 5px;" | +/-
Line 166: Line 190:
* '''CK 20'''   
* '''CK 20'''   
* '''CK 7'''  
* '''CK 7'''  
* Synapthosin  
* [[Synapthosin|Synap-          thosin]]
* pancreatic polypeptide  
* pancreatic polypeptide  
* CEA  
* [[CEA]]
* CA 19-9  
* [[CA 19-9]]
* CA 125  
* [[CA-125|CA -125]]
| colspan="4" style="background: #F5F5F5; padding: 5px;" |Unfortunately, compared to the other carcinoid tumors of appendix, GCC is more aggressive and patients with GCC generally present at higher stages. Hence, in addition to the above mentioned general findings for appendix cancers, imaging studies should look for evidences of peritoneal involvement, bone metastasis, lymphadenopathy, and metastatic lesions in ovaries and/or prostate.  
| colspan="4" style="background: #F5F5F5; padding: 5px;" |Unfortunately,<br> compared to the other carcinoid tumors of appendix,<br> GCC is more aggressive and <br>patients with GCC generally present at higher stages.<br> Hence, in addition to<br> the above mentioned <br>general findings for appendix cancers, <br>imaging studies should <br>look for evidences of peritoneal involvement,<br> bone metastasis, lymphadenopathy, <br>and metastatic lesions<br> in ovaries and/or prostate.  
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
'''Gross pathology''':
'''Gross<br>pathology''':
:* No gross tumor might be present  
* No gross<br>tumor might<br>be present  
:* Thickened appendiceal wall  
* Thickened<br>appendiceal<br>wall  
'''Microscopic appearance:'''  
'''Microscopic<br>appearance:'''  
*GCC Generally spares mucosa and infiltrates muscularis propria and periappendiceal fat
*GCC Generally<br>spares mucosa<br>and<br>infiltrates<br>muscularis<br>propria<br>and<br>peri-<br>appendiceal<br> fat
*Tumor cell clusters  
*Tumor<br> cell clusters  
*Crypt-like structures  
*Crypt-like<br> structures  
*Tubules of mucus-secreting cells distended with mucin resembling goblet cells
*Tubules of<br> mucus-secreting <br>cells distended<br> with mucin <br>resembling<br> goblet cells
*Eosinophilic cytoplasm resembling carcinoid tumors
*Eosinophilic<br> cytoplasm <br>resembling<br> carcinoid <br>tumors
*Pools of extracellular mucin
*Pools of <br>extracellular<br> mucin
*Scattered Paneth cells in tumors with crypt like structures
*Scattered<br>Paneth cells<br>in tumors<br>with crypt<br>like<br>structures
*Extensive perineural invasion  
*Extensive<br>perineural<br>invasion  
*'''Carcinomatous growth pattern:'''
*'''Carcinomatous<br>growth<br>pattern:'''  
::*Cribriform growth pattern, solid sheets of infiltrating signet ring cells
*Cribriform<br>growth<br>pattern,<br>solid<br>sheets of<br>infiltrating<br>signet ring<br>cells
::*Nuclear pleomorphism  
*Nuclear<br>pleomorphism  
::*Increased mitotic activity
*Increased<br>mitotic<br>activity
| style="background: #F5F5F5; padding: 5px;" |[[Biopsy]]
|-  
|-  
! colspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;"|Diseases
! colspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diseases
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Abdominal pain'''
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Abdo-<br>minal<br>pain'''
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Change in girdle size
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Change in girdle size
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Change in bowel habits
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Bowel
! colspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |  '''Other symptoms'''
freq-
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Abdominal mass
 
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Abdominal tenderness
uency
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other physical examination findings
! colspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |  '''Other'''
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Urinary 5-hydroxyindoleacetic acid (5-HIAA) and/or Serum Chromogranin A (CgA)'''
'''symptoms'''
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Abdo-<br>minal<br> mass
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Abdo-<br>minal<br>tender-<br>ness
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other
physical  
 
exami-
 
nation
 
findings
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''5-HIAA<br>and/or<br>CgA'''
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other lab findings
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other lab findings
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |CT scan
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |CT scan
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |MRI
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |MRI
! colspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Utrasounography
! colspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Utra-
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other diagnostic studies and imaging modalities
sounography
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Histopathology
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other
| style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Gold standard'''
diagnostic
 
studies
 
and
 
imaging
 
modalities
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Histo-
pathology
|-
|-
| rowspan="4" style="background: #DCDCDC; padding: 5px; text-align: center;" |Appendix Mucocele
| rowspan="4" style="background: #DCDCDC; padding: 5px; text-align: center;" |Appendix Mucocele
| style="background: #DCDCDC; padding: 5px;" |Mucosal hyperlasia
| style="background: #DCDCDC; padding: 5px;" |Mucosal
[[hyperplasia]]
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" |<nowiki>-</nowiki>
| style="background: #F5F5F5; padding: 5px;" |<nowiki>-</nowiki>
| style="background: #F5F5F5; padding: 5px;" |<nowiki>-</nowiki>
| style="background: #F5F5F5; padding: 5px;" |<nowiki>-</nowiki>
| rowspan="2" style="background: #F5F5F5; padding: 5px;" |
| rowspan="2" style="background: #F5F5F5; padding: 5px;" |
* '''Generally asymptomatic'''  
* '''Generally asympto-<br>matic'''  
* Benign even after rupture  
* Benign<br>even<br>after<br>rupture  
| style="background: #F5F5F5; padding: 5px;" |<nowiki>-</nowiki>
| style="background: #F5F5F5; padding: 5px;" |<nowiki>-</nowiki>
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+/-</nowiki>
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+/-</nowiki>
Line 223: Line 268:
| rowspan="4" style="background: #F5F5F5; padding: 5px;" |
| rowspan="4" style="background: #F5F5F5; padding: 5px;" |
*  
*  
* low attenuation well defined mass in RLQ near cecum
* low<br>attenuation<br> well<br> defined<br> mass in<br> RLQ<br>near<br>cecum
* Inflammation is the key to distinguish between appendicitis and mucocele
* [[Inflammation]]<br> is the key to<br> distinguish<br> between<br> appendicitis<br> and<br> mucocele
* Wall thickness does not distinguish between malignant and benign mucocele
* Wall<br> thickness<br>'''does not'''<br> distinguish<br> between<br> malignant <br>and <br>benign<br> mucocele
* Intramural nodule is a sign of neoplastic lesions  
* Intramural<br> nodule <br>is a sign of<br> neoplastic<br> lesions. <sup>4</sup>
* '''Imaging is not a reliable method to distinguish between neoplastic and nonneoplastic lesions''', hence every patient should undergo surgery, appendectomy and histopathologic evaluation of the lesion
| rowspan="4" style="background: #F5F5F5; padding: 5px;" | [https://radiopaedia.org/articles/appendiceal-mucocele-2 Rounded<br>right iliac<br> fossa mass]
| rowspan="4" style="background: #F5F5F5; padding: 5px;" |<nowiki> |</nowiki>[https://radiopaedia.org/articles/appendiceal-mucocele-2 Rounded right iliac fossa mass]
*'''T1:''' The<br>signal<br> depends<br> on <br> the mucin<br> concen-<br> tration,<br> may be<br> from<br> hypointense<br> to<br> isointense
* '''T1:''' the signal depends on the mucin concentration, may be from hypointense to isointense
*'''T2:'''<br> Hyperintense
* '''T2:''' hyperintense
 
*  
*  
| rowspan="4" style="background: #F5F5F5; padding: 5px;" |
| rowspan="4" style="background: #F5F5F5; padding: 5px;" |
* Histologically benign
* Histo-<br>logically<br>benign
* [[Appendix cancer echocardiography and ultrasound|Dilated fluid filled appendix in the right lower quadrant.]]
* Dilated<br>fluid<br>filled<br>appendix<br>in the<br>RLQ.  
* Thin appendiceal wall  
* Thin<br>appendiceal<br>wall  
* A focus of hyperechogenicity
* A focus<br>of<br>hyper-<br>echogenicity
* '''Since generally there is no inflammation'''
* '''Since<br> generally<br> there is<br> no [[inflammation]]'''
* Surrounding fat is normal.  
* Surrounding <br>fat<br> is normal.  
* No peri-appendiceal fluid or collection
* No peri-<br>appendiceal <br>fluid or<br>collection
| rowspan="4" style="background: #F5F5F5; padding: 5px;" |N/A
| rowspan="4" style="background: #F5F5F5; padding: 5px;" |N/A
| style="background: #F5F5F5; padding: 5px;" |Similar to hyperplastic colon polyp
| style="background: #F5F5F5; padding: 5px;" |Similar<br>to<br>hyperplastic<br>colon<br>polyp
| style="background: #F5F5F5; padding: 5px;" |[[Biopsy]]
|-
|-
| style="background: #DCDCDC; padding: 5px;" |Simple or retention cyst
| style="background: #DCDCDC; padding: 5px;" |Simple
or
 
[[Mucous retention cyst|retention]]
 
[[Mucous retention cyst|cyst]]
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" |<nowiki>-</nowiki>
| style="background: #F5F5F5; padding: 5px;" |<nowiki>-</nowiki>
Line 254: Line 301:
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" |N/A
| style="background: #F5F5F5; padding: 5px;" |N/A
| style="background: #F5F5F5; padding: 5px;" |Degenerative epithelial changes because of obstruction
| style="background: #F5F5F5; padding: 5px;" |Degenerative<br>epithelial<br>changes<br>because of<br>obstruction
| style="background: #F5F5F5; padding: 5px;" | Biopsy
|-
|-
| style="background: #DCDCDC; padding: 5px;" | Mucinous cystadenomas
| style="background: #DCDCDC; padding: 5px;" | Mucinous cyst-
adenomas
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+/-</nowiki>
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+/-</nowiki>
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+/-</nowiki>
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+/-</nowiki>
| style="background: #F5F5F5; padding: 5px;" | +/-Diarrhea
| style="background: #F5F5F5; padding: 5px;" | <math>\uparrow</math><math>\downarrow</math>
<nowiki>+/-</nowiki>Constipation
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* '''Generally asymptomatic'''  
* '''Generally asympto-<br>matic'''  
* Rupture may lead to Pseudomyxoma peritonei  
* Rupture<br>may<br>lead<br>to<br>Pseudo-<br>myxoma<br>peritonei  
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+/-</nowiki>
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+/-</nowiki>
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+/-</nowiki>
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+/-</nowiki>
| rowspan="2" style="background: #F5F5F5; padding: 5px;" |If develop pseudomyxoma peritonei:
| rowspan="2" style="background: #F5F5F5; padding: 5px;" |If develop  
[[Pseudomyxoma peritonei|pseudo-<br>myxoma<br> peritonei]]:<br>
* [[Ascites]]  
* [[Ascites]]  
* Shifting dullness  
* [[Shifting dullness|Shifting<br>dullness]]
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* CEA  
* [[CEA]]
* CA 19-9  
* [[CA 19-9]]
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Histologically benign
* Histo-<br>logically<br>benign
* Similar to colon adenomatous polyps or villous adnomas
* Similar<br>to<br>colon<br>adenomatous<br>polyps or<br> villous <br>adnomas
| style="background: #F5F5F5; padding: 5px;" |Biopsy
|-
|-
| style="background: #DCDCDC; padding: 5px;" |  Mucinous cystadenocarcinomas
| style="background: #DCDCDC; padding: 5px;" |  Mucinous [[Cystadenocarcinoma staging|cystadeno-]]
[[Cystadenocarcinoma staging|carcinomas]]
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+/-</nowiki>
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+/-</nowiki>
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+/-</nowiki>
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+/-</nowiki>
| style="background: #F5F5F5; padding: 5px;" | +/-Diarrhea
| style="background: #F5F5F5; padding: 5px;" | <math>\uparrow</math><math>\downarrow</math>
<nowiki>+/-</nowiki>Constipation
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+/-</nowiki>
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+/-</nowiki>
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+/-</nowiki>
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+/-</nowiki>
Line 289: Line 335:
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* CEA  
* [[CEA]]
* CA 19-9  
* [[CA 19-9]]
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Glandular invasion into the stoma
* Glandular<br>invasion<br>into the<br>stoma
* Pseudomyxoma peritonei
* Pseudo-<br>myxoma<br>peritonei
| style="background: #F5F5F5; padding: 5px;" |[[Biopsy]]
|-  
|-  
! colspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;"|Diseases
! colspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diseases
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Abdominal pain'''
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Abdo-<br>minal<br>pain'''
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Change in girdle size
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Change in girdle size
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Change in bowel habits
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Bowel<br>freq-<br>uency
! colspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |  '''Other symptoms'''
! colspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |  '''Other'''
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Abdominal mass
'''symptoms'''
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Abdominal tenderness
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Abdo-<br>minal<br> mass
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other physical examination findings
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Abdo-<br>minal<br> tender-<br>ness
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Urinary 5-hydroxyindoleacetic acid (5-HIAA) and/or Serum Chromogranin A (CgA)'''
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other
physical<br>exami-<br>nation<br>findings
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''5-HIAA<br>and/or<br>CgA'''
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other lab findings
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other lab findings
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |CT scan
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |CT scan
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |MRI
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |MRI
! colspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Utrasounography
! colspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Utra-<br>sounography<br>
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other diagnostic studies and imaging modalities
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other<br>diagnostic<br>studies<br>and<br>imaging<br>modalities<br>
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Histopathology
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Histo-
| style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Gold standard'''
pathology
|-
|-
| colspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" | [[Ovarian cancer differential diagnosis|Ovarian cancer]]
| colspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" | [[Ovarian cancer differential diagnosis|Ovarian cancer]]
| style="background: #F5F5F5; padding: 5px;" | +/-
| style="background: #F5F5F5; padding: 5px;" | +/-
| style="background: #F5F5F5; padding: 5px;" | +/-
| style="background: #F5F5F5; padding: 5px;" | +/-
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+/-</nowiki>Constipation
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+/-</nowiki><math>\downarrow</math>
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Pelvic/abdominal pain or pressure  
* Pelvic/         [[abdominal         pain]] or           pressure  
* Vaginal bleeding/discharge  
* [[Vaginal         bleeding]]/ discharge  
* Dyspnea  
* [[Dyspnea|Dyspne]]<nowiki/>a
* GI disturbance  
* GI               disturbance  
| style="background: #F5F5F5; padding: 5px;" | +
| style="background: #F5F5F5; padding: 5px;" | +
| style="background: #F5F5F5; padding: 5px;" | +/-
| style="background: #F5F5F5; padding: 5px;" | +/-
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* [[Ascites]]  
* [[Ascites]]  
* Shifting dullness  
* [[Shifting         dullness]]
* Fever  
* [[Fever]]
* Pleural effusion  
* [[Pleural       effusion]]
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* '''Depends on the underlying etiology'''
* '''Depends<br>on<br>the<br>underlying<br>etiology'''
* Iron
* Iron
* HCG
* [[Human chorionic gonadotropin|HCG]]
* LDH
* [[Lactate dehydrogenase|LDH]]
* Calcium
* [[Calcium]]
* Estrogen
* [[Estrogen]]
* progestron
* Progestron
* Testosterone  
* [[Testosterone|Testos-<br>terone]]
* AFP
* [[Alpha-fetoprotein|AFP]]
* CA 125
* [[CA-125]]
* Ki 67
* Ki 67
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Adnexal mass
* Adnexal<br> mass
* Adenexal Cyst (simple or complex)
* Adenexal <br> Cyst<br>(simple<br>or<br>complex)
* Fluid accumulation
* Fluid <br>accumulation
* Endometrial thickening
* Endometrial <br>thickening
* calcification
* Calcification
* Pleural effusion
* Pleural <br>effusion
* Peritoneal involvement
* Peritoneal<br>involvement
* Lymphandenopathy
* [[Lymphadenopathy|Lympha-denopathy]]
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Adnexal mass
* Adnexal <br> mass
* Adenexal Cyst (simple or complex)
* Adenexal <br> cyst<br>(simple<br>or<br>complex)
* Except for [[Thecoma]], ovarian masses are generally hyperintense on T1 and hypo or isointense on T2 imaging
* Except for<br>[[Thecoma]],<br>ovarian<br>masses <br>are <br>generally hyperintense <br>on T1 and<br>hypo or<br> sointense <br> on <br>T2 imaging
* Fluid accumulation
* Fluid<br>accumulation
* Endometrial thickening
* Endometrial<br>thickening
* calcification
* Calcification
* Pleural effusion
* Pleural <br>effusion
* Peritoneal involvement
* Peritoneal <br>involvement
* Lymphandenopathy
* Lympha-<br>denopathy
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Adnexal mass
* Adnexal <br>mass
* Adenexal Cyst (simple or complex)
* Adenexal <br> cyst<br> (simple<br> or<br> complex)
* Fluid accumulation
* Fluid <br>accumulation
* Increased [[Doppler ultrasound|Doppler]] flow  
* Increased <br>[[Doppler ultrasound|Doppler]]<br> flow  
* Endometrial thickening
* Endometrial<br>thickening
* calcification
* Calcification
| style="background: #F5F5F5; padding: 5px;" | N/A
| style="background: #F5F5F5; padding: 5px;" | N/A
| style="background: #F5F5F5; padding: 5px;" | Depends on the tumor type. You may find the details [[Ovarian cancer differential diagnosis|here]].
| style="background: #F5F5F5; padding: 5px;" | Depends<br>on the<br>tumor type.<br>You may<br>find the<br>details<br>[[Ovarian cancer differential diagnosis|here]].
| style="background: #F5F5F5; padding: 5px;" |[[Biopsy]]
|-
|-
| colspan="2" style="background: #DCDCDC; padding: 5px;" |[[Colorectal cancer]]
| colspan="2" style="background: #DCDCDC; padding: 5px;" |[[Colorectal cancer]]
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+/-</nowiki>
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+/-</nowiki>
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+/-</nowiki>
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+/-</nowiki>
| style="background: #F5F5F5; padding: 5px;" | +/-Diarrhea
| style="background: #F5F5F5; padding: 5px;" | <math>\uparrow</math><math>\downarrow</math>
+ Constipation
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* [[Weight loss]]
* [[Weight loss]]
* [[Fatigue]]
* [[Fatigue]]
* Low caliber of stools
* Low caliber<br>of stools
* [[Nausea and vomiting]]
* Nausea<br>and<br>vomiting
* [[Mucus]] in stools
* [[Mucus]] in<br>stools
* [[Rectal prolapse]]
* [[Rectal prolapse]]
* In Carcinoids :
* '''in Carcinoids:'''
** [[Weight gain|Weight loss]]
*''[[Weight gain|Weight<br>loss]]''
** [[Weakness]]
*''[[Weakness]]''
** [[Flushing (physiology)|Flushing]]
* ''[[Flushing (physiology)|Flushing]]''
** [[Wheezing]]
* ''[[Wheezing]]''
** [[Shortness of breath]]
* ''[[Shortness of breath]]''
** [[Palpitations]]
* ''[[Palpitations]]''
** [[Leg edema]]
*'' [[Leg edema]]''
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+</nowiki>
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+</nowiki>
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+/-</nowiki>
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+/-</nowiki>
| style="background: #F5F5F5; padding: 5px;" |'''Colonoscopy'''
| style="background: #F5F5F5; padding: 5px;" |'''Colonoscopy'''
''Adenocarcinoma''
''[[Adenocarcinoma|Adeno-]]''
* [[Polyp|Polyps]] (villous, tubular, tubulo-villous)
 
* [[Ulcer|Ulcerating polyps]]
''[[Adenocarcinoma|carcinoma]]''
* [[Cancerous]][[lesions]]
* [[Polyp|Polyps]]<br>(villous,<br>tubular,<br>tubulo-<br>villous)
* [[Ulcer|Ulcerating<br>polyps]]
* [[Cancerous]]<br>[[lesions]]
''Carcinoids''
''Carcinoids''
* [[Infiltration (medical)|Infiltrating]], [[Ulceration|ulcerating]] or fungating lesions in the [[Colon (anatomy)|wall of colon]]
* [[Infiltration (medical)|Infiltrating]], [[Ulceration|ulcerating]]<br>or<br>fungating<br>lesions in<br>the<br> wall of<br>colon


| style="background: #F5F5F5; padding: 5px;" |<nowiki>-/+(Carcinoid tumors)</nowiki>
| style="background: #F5F5F5; padding: 5px;" | -/+([[Carcinoid Tumor|Carcinoid tumor]]<nowiki/>s)
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* [[Anemia]]
* [[Anemia]]
* Positive [[Fecal occult blood test]]
* Positive<br>fecal<br>occult<br>blood<br>test
* High levels of [[CEA]] and [[CA 19-9]]
* High<br>levels<br>of<br>[[CEA]]<br>and<br>[[CA 19-9]]
| style="background: #F5F5F5; padding: 5px;" | luminal narrowing, [[intestinal]] wall thickening,[[intussusception]], [[bowel obstruction]], [[Metastases|hepatic metastases]], intestinal perforation,[[enlarged lymph nodes]]
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* [[Tumor]] mass and the extension of [[tumor]] to other structures
*luminal<br>narrowing<br>
*[[Intestinal]]<br>wall<br>thickening,<br>
*[[Intussusception|Intus-<br>susception]],<br>
*[[Bowel obstruction]],<br>
*[[Metastases|Hepatic<br>metastases]],
*Intestinal<br>perforation,<br>
*[[Lymphadenopathy|Enlarged<br>lymph<br>nodes]]
| style="background: #F5F5F5; padding: 5px;" |
* [[Tumor]]<br> mass<br> and <br>the<br> extension<br> of<br> [[tumor]] to<br> other<br> structures


* [[liver]], [[lung]] and [[brain]] [[Metastasis]]  
* [[liver]],<br>[[lung]]<br>and<br>[[brain]]<br>[[Metastasis]]  
| style="background: #F5F5F5; padding: 5px;" |Generally not recommended: may evaluate liver metastasis or presence of fluid in abdominal cavity, but it is neither sensitive nor specific.
| style="background: #F5F5F5; padding: 5px;" |Generally<br>not<br>recommended:<br>may<br>evaluate<br>liver metastasis<br>or presence<br>of fluid<br>in abdominal<br>cavity, but it is <br>neither <br>sensitive<br> nor<br> specific.
| style="background: #F5F5F5; padding: 5px;" |PET scan, Endoscopy, Colonoscopy,  
| style="background: #F5F5F5; padding: 5px;" |[[Positron emission tomography|PET<br>scan]],<br>[[Endoscopy]],<br>[[Colonoscopy]],  


Barium enema
[[Lower gastrointestinal series|Barium enema]]


| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Depends on the tumor type.. You will find more information [[Colorectal cancer differential diagnosis|here]]
* Depends<br>on the<br>tumor<br>type.<br>You will<br>find more<br>information<br>[[Colorectal cancer differential diagnosis|here]]
| style="background: #F5F5F5; padding: 5px;" |[[Biopsy]]
|-
|-
| colspan="2" style="background: #DCDCDC; padding: 5px;" |[[Pseudomyxoma peritonei differential diagnosis|Pseudomyxoma peritonei]]
| colspan="2" style="background: #DCDCDC; padding: 5px;" |[[Pseudomyxoma peritonei differential diagnosis|Pseudomyxoma]]
[[Pseudomyxoma peritonei differential diagnosis|peritonei]]
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+</nowiki>
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+</nowiki>
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+</nowiki>
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+</nowiki>
| style="background: #F5F5F5; padding: 5px;" | +/-Diarrhea
| style="background: #F5F5F5; padding: 5px;" | <math>\uparrow</math><math>\downarrow</math>
<nowiki>+/-</nowiki>Constipation
| style="background: #F5F5F5; padding: 5px;" |Bloating
| style="background: #F5F5F5; padding: 5px;" |Bloating
| style="background: #F5F5F5; padding: 5px;" |<nowiki>-</nowiki>
| style="background: #F5F5F5; padding: 5px;" |<nowiki>-</nowiki>
Line 431: Line 484:
| style="background: #F5F5F5; padding: 5px;" |[[Ascites]]
| style="background: #F5F5F5; padding: 5px;" |[[Ascites]]


Shifting dullness
[[Shifting             dullness]]
| style="background: #F5F5F5; padding: 5px;" |<nowiki>-</nowiki>
| style="background: #F5F5F5; padding: 5px;" |<nowiki>-</nowiki>
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Non specific
* Nonspecific
* Depends on the etiology of the disease
* Depends<br>on the<br>[[etiology]]<br>of the<br>disease
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Low-attenuation
* Low-<br>attenuation<br>Scalloping<br> of the<br> visceral<br> surfaces<br> differentiates<br> [[Pseudomyxoma peritonei|pseudo-<br>myxoma]] <br>from other<br> causes of<br>[[peritonitis]].
 
* Typically <br>does not <br>invade<br> visceral <br>organs<br> or spread<br> by [[lymphatic]]<br> or<br> hemato-<br>genous <br>routes <br>unlike<br>mucinous<br>carcino-<br>matosis
* Scalloping of the visceral surfaces differentiates pseudomyxoma from other causes of peritnoitis.
* Typically does not invade visceral organs or spread by [[lymphatic]] or hematogenous routes unlike mucinous carcinomatosis
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Characterized by a mass which is hypointense on T1-weighted MRI and hyperintense on T2-weighted MRI. MRI has better sensitivity in detecting ascites fluid and mucocele.
Charact-<br> erized <br>by a mass<br>which is<br>hypointense<br>on<br>T1-weighted<br>MRI<br>and<br>hyperintense<br>on<br>T2-weighted<br>[[Magnetic resonance imaging|MRI]].<br>[[Magnetic resonance imaging|MRI]] has<br> better<br>sensitivity<br>in<br>detecting<br>[[ascites]]<br>fluid <br>and<br>[[mucocele]].
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* The echoes within pseudomyxoma peritonei are not mobile.
* The echoes<br>within<br>[[Pseudomyxoma peritonei|pseudo-<br>myxoma <br>peritonei]] <br>are not <br>mobile.
* Echogenic septations within the gelatinous ascites.
* Echogenic<br>septations <br>within<br> the<br> gelatinous<br> ascites.
* Scalloping of the [[hepatic]] and splenic margins
* Scalloping <br>of the<br> [[hepatic]] <br>and<br>splenic <br>margins
| style="background: #F5F5F5; padding: 5px;" |18F-FDG [[PET scan]]  
| style="background: #F5F5F5; padding: 5px;" |18F-FDG<br> [[PET scan]]  
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Depending on [[WHO]]<nowiki/>classification, whether it's low or high grade with cellular atypia or acellular mucin. ( DPAM, PMCA)
* Depending<br> on<br> [[WHO]]<nowiki/> <br>classification,<br> whether it is <br>low or high <br>grade<br> with <br>cellular atypia <br>or acellular mucin. <br>( DPAM, PMCA)
* Gelatinous [[ascites]] in peritoneum and [[visceral]]<nowiki/>organs,usually underneath the right hemidiaphragm, liver.
* Gelatinous<br> [[ascites]] <br>in peritoneum <br>and<br> [[visceral]]<br><nowiki/>organs,<br>usually <br>underneath<br> the right<br> hemidiaphragm,<br> liver.
* Omental cake
* Omental cake
** Immunohistochemisty
[[Immunohistochemistry|'''IHC''']]''':'''
*:* CK 20
*CK 20
*:* [[CDX2]]
* [[CDX2]]
*:* [[MUC2]]
* [[MUC2]]
*:* MUC5AC
* MUC5AC
| style="background: #F5F5F5; padding: 5px;" |
* Diagnostic laparascopy/laparatomy
|-
|-
| colspan="2" style="background: #DCDCDC; padding: 5px;" |[[Carcinoid syndrome]]
| colspan="2" style="background: #DCDCDC; padding: 5px;" |[[Carcinoid syndrome]]
| style="background: #F5F5F5; padding: 5px;" |<nowiki>-/+</nowiki>
| style="background: #F5F5F5; padding: 5px;" |<nowiki>-/+</nowiki>
| style="background: #F5F5F5; padding: 5px;" |<nowiki>-</nowiki>
| style="background: #F5F5F5; padding: 5px;" |<nowiki>-</nowiki>
| style="background: #F5F5F5; padding: 5px;" |Diarrhea
| style="background: #F5F5F5; padding: 5px;" |<math>\uparrow</math>
| style="background: #F5F5F5; padding: 5px;" |Flushing
| style="background: #F5F5F5; padding: 5px;" |
 
* [[Flushing]]
Palpitation
* [[Palpitation]]
 
* [[Dyspnea]]
Dyspnea
| style="background: #F5F5F5; padding: 5px;" |<nowiki>-</nowiki>
| style="background: #F5F5F5; padding: 5px;" |<nowiki>-</nowiki>
| style="background: #F5F5F5; padding: 5px;" |<nowiki>-</nowiki>
| style="background: #F5F5F5; padding: 5px;" |<nowiki>-</nowiki>
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Tricuspid regurgitation
** [[Tricuspid regurgitation|TR]][[Heart murmur|murmur]]
* murmur
** [[Wheeze|Wheezing]]
* Wheezing


| style="background: #F5F5F5; padding: 5px;" |<nowiki>+</nowiki>
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+</nowiki>
| style="background: #F5F5F5; padding: 5px;" |Depends on the tumor [[Neuroendocrine tumors laboratory findings|type]]:
| style="background: #F5F5F5; padding: 5px;" |Depends<br>on the<br>tumor<br>[[Neuroendocrine tumors laboratory findings|type]]:
* Ki67
* Ki67
* N-terminal pro–B-type natriuretic peptide
* N-terminal<br>pro–B-<br>type<br>natriuretic<br>peptide
* [[Substance P]]
* [[Substance P]]
* [[Neurotensin]]
* [[Neurotensin]]
* [[Bradykinin]]
* [[Bradykinin]]
* [[Human chorionic gonadotropin]]
* Human<br>chorionic<br>gonadotropin
* Neuropeptide L
* Neuro-<br>peptide L
* [[Pancreatic polypeptide]]
* Pancreatic<br>polypeptide
*  
*  
| style="background: #F5F5F5; padding: 5px;" |Depends on the primary tumor location and type
| colspan="3" style="background: #F5F5F5; padding: 5px;" |Depends on the <br>primary tumor location and type
| style="background: #F5F5F5; padding: 5px;" |Depends on the primary tumor location and type
| style="background: #F5F5F5; padding: 5px;" |Depends on the primary tumor location and type
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* [[Somatostatin]] [[scintigraphy]] with 111-indium-octreotide
* [[Somatostatin]]<br>[[scintigraphy]]<br>with<br>111-indium-<br>octreotide
* [[Bone]] [[scintigraphy]] with 99mTc-methylene diphosphonate (99mTcMDP)
* [[Bone]]<br>[[scintigraphy]]<br>with 99mTc-<br>methylene<br> diphosphonate<br>(99mTcMDP)
* [[Positron emission tomography]] (PET)
* Positron<br>emission<br>tomography<br>(PET)
* 123I-MIBG scintigraphy
* 123I-MIBG<br> scintigraphy
* [[Capsule endoscopy]] (CE)
* [[Capsule endoscopy]]<br>(CE)
* [[Enteroscopy]]
* [[Enteroscopy]]
* Angiography
* Angiography
* MRI Angiography
* MR Angiography
* [[Endoscopic]] [[ultrasonography]] (EUS)  
* [[Endoscopic]]<br>[[ultrasonography]] (EUS)  


| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Salt and pepper nuclei  
* Salt<br> and<br> pepper<br> nuclei  
* Cellular uniformity
* Cellular<br> uniformity
* Central ovoid nucleus
* Central <br>ovoid<br> nucleus
* Presence of ribbons, trabeculae, nesting, glands, gyriform, pseudorosettes
* Presence of <br>ribbons,<br> trabeculae, <br>nesting, <br>glands,<br> gyriform,<br> pseudorosettes
* Insulinoma (Amyloid deposition)
* Insulinoma <br>(Amyloid <br>deposition)
* Somatostatinom (Psammoma bodies)
* Somatostatinom <br>(Psammoma <br>bodies)
* Hyaline globules
* Hyaline <br>globules
* '''IHC'''
[[Immunohistochemistry|'''IHC''']]''':'''
** Synaptophysin (almost always, strongly and diffusely expressed )
* Synaptophysin <br>(almost<br> always, <br>strongly <br>and <br>diffusely<br> expressed )
** Chromogranin A
* CGA
** CD56 and PGP ( less specific)
* CD56 and PGP<br>( less <br>specific)
** PDX1 and ISL1
* PDX1
| style="background: #F5F5F5; padding: 5px;" |[[Biopsy]] from the tumor is the gold standard method of diagnosis, meanwhile
* ISL1
 
5-HIAA (5-hydroxyindoleacetic acid) is the most specific marker of carcinoid tumors
|-
|-
| colspan="2" style="background: #DCDCDC; padding: 5px;" |[[Appendicitis differential diagnosis|Appendicitis]] <sup>3</sup>
| colspan="2" style="background: #DCDCDC; padding: 5px;" |[[Appendicitis differential diagnosis|Appendicitis]] <sup>3</sup>
| style="background: #F5F5F5; padding: 5px;" | Periumbelical, RLQ
| style="background: #F5F5F5; padding: 5px;" | PU,<br>RLQ
| style="background: #F5F5F5; padding: 5px;" |<nowiki>-</nowiki>
| style="background: #F5F5F5; padding: 5px;" |<nowiki>-</nowiki>
| style="background: #F5F5F5; padding: 5px;" | +/- Diarrhea
| style="background: #F5F5F5; padding: 5px;" | <math>\uparrow</math><math>\downarrow</math>
* Intermittent
* Secretory type
| style="background: #F5F5F5; padding: 5px;" |[[Nausea and vomiting|Nausea<br> &<br>vomiting]],<br>decreased
<nowiki>+</nowiki> Constipation
[[appetite]]
| style="background: #F5F5F5; padding: 5px;" |[[Nausea and vomiting|Nausea & vomiting]],[[decreased appetite]]
Anorexia


| style="background: #F5F5F5; padding: 5px;" |<nowiki>+/-</nowiki>
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+/-</nowiki>
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+</nowiki>
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+</nowiki>
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* [[Rebound tenderness]]
* Rebound<br>tenderness
* [[Abdominal guarding]]
* Abdominal<br>guarding
* [[Rovsing's sign]]
* [[Rovsing's sign|Rovsing's<br>sign]]
* [[Psoas sign]]
* [[Psoas sign|Psoas<br>sign]]
* [[Obturator sign]]
* [[Obturator sign|Obturator<br>sign]]
* TR exam might reveal tenderness in the [[rectovesical pouch]]  
* [[Rectal examination|TR exam]]<br>might reveal<br>tenderness<br>in the<br>[[Rectovesical excavation|rectovesical<br>pouch]]  
* [[Tachypnea]]  
* [[Tachypnea]]  
* Tachycardia  
* Tachycardia  
Line 545: Line 586:
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* [[Leukocytosis]]
* [[Leukocytosis]]
* Left shift
* [[Left shift]]
| style="background: #F5F5F5; padding: 5px;" | Appendiceal wall thickening /perforation
| style="background: #F5F5F5; padding: 5px;" |  
*Appendiceal<br> wall<br> thickening<br> /perforation


peri-appendiceal inflammation, fluid accumulation,fat stranding
*Peri-<br>appendiceal<br>[[inflammation]],<br>fluid<br>accumulation,<br>
*Fat<br>stranding


| style="background: #F5F5F5; padding: 5px;" |Increased fluid signal on T2 weighted sequence
| style="background: #F5F5F5; padding: 5px;" |Increased<br>  fluid<br>  signal <br> on T2 <br> weighted <br> sequence
| style="background: #F5F5F5; padding: 5px;" |Evidences of [[inflammation]]
| style="background: #F5F5F5; padding: 5px;" |Evidences<br>  of<br>  [[inflammation]]
* Dilated appendix
* Dilated<br> appendix
* Periappendiceal fluid collection
* Peri-<br>appendiceal <br> fluid<br>  collection
* Distinct appendix wall layers
* Distinct <br> [[Vermiform appendix|appendix]]<br>  wall<br>  layers
| style="background: #F5F5F5; padding: 5px;" |[[Tc-99m]] labeled anti-[[CD15]] [[antibodies]]  
| style="background: #F5F5F5; padding: 5px;" |[[Tc-99m]] <br> labeled <br> anti-<br> [[CD15]]<br>  [[antibodies]]  
| style="background: #F5F5F5; padding: 5px;" |Evidences of [[inflammation]]
| style="background: #F5F5F5; padding: 5px;" |Evidences <br> of<br>  [[inflammation]]
| style="background: #F5F5F5; padding: 5px;" |A combination of Imaging (ultrasonography or CT scan, while CT scan is more sensitive), physical exam and history
[[Appendicitis diagnostic scoring|Alvarado Score]]
|-  
|-  
! colspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;"|Diseases
! colspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diseases
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Abdominal pain'''
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Abdo-<br>minal<br>pain'''
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Change in girdle size
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Change in girdle size
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Change in bowel habits
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Bowel
! colspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |  '''Other symptoms'''
frequ-
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Abdominal mass
f
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Abdominal tenderness
ency
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other physical examination findings
! colspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |  '''Other'''
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Urinary 5-hydroxyindoleacetic acid (5-HIAA) and/or Serum Chromogranin A (CgA)'''
'''symptoms'''
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Abdo-<br>minal<br> mass
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Abdo-<br>minal<br> tender-<br>ness
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other
physical  
 
exami-
 
nation
 
findings
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''5-HIAA<br>and/or<br>CgA'''
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other lab findings
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other lab findings
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |CT scan
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |CT scan
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |MRI
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |MRI
! colspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Utrasounography
! colspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Utra-
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other diagnostic studies and imaging modalities
sounography
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Histopathology
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other
| style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Gold standard'''
diagnostic
 
studies
 
and
 
imaging
 
modalities
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Histo-
pathology
|}
|}


<small><sup>1</sup></small> Adenocarcinomas usually present with appendicitis, barely they might present with [[Pseudomyxoma peritonei]]; meanwhile Pseudomyxoma peritonei is more prevalent in perforated mucocele, goblet cell tumor or high stages of adenocarcinoma.
<small><sup>1</sup></small> [[Adenocarcinoma]]<nowiki/>s usually present with appendicitis, barely they might present with [[Pseudomyxoma peritonei]]; meanwhile [[pseudomyxoma peritonei]] is more prevalent in perforated [[mucocele]], goblet cell tumor or high stages of [[Adenocarcinoma|adenocarcinoma.]]


<sup>2</sup> Generally appendix carcinoids are asymptomatic, they were only become symptomatic if they metastasize to the liver, or in rare cases make an obstruction and present with appendicitis which is quit uncommon in appendiceal carcinoids compared to appendiceal adenocarcinoma.  Any patient with carcinoid syndrome should be evaluated for appendix carcinoids.
<sup>2</sup> Generally [[Vermiform appendix|appendix]] [[Carcinoid Tumor|carcinoids]] are [[asymptomatic]], they were only become symptomatic if they [[Liver mass|metastasize to the liver,]] or in rare cases make an obstruction and present with appendicitis which is quit uncommon in appendiceal carcinoids compared to appendicea[[Adenocarcinoma|l adenocarcinoma]].  Any patient with [[carcinoid syndrome]] should be evaluated for [[Carcinoid|appendix carcinoid]]<nowiki/>s.


<sup>3</sup> Every patient with appendicitis should be evaluated for appendix cancer, 0.5 in 100 appendicitis cases are because of appendix cancer.
<sup>3</sup> Every patient with appendicitis should be evaluated for appendix cancer, 0.5 in 100 appendicitis cases are because of appendix cancer.


<nowiki>*</nowiki>'''Abbreviations:''' RLQ: Right Lower Quadrant, AFP:Alpha Fetoprotein, HCG: Human chorionic gonadotropin, LDH: Lactate Dehydrogenase, CEA: Carcinoembryonic antigen, CA 125: Cancer antigen 125
<sup>4</sup> '''[[Imaging]]''' '''is not a reliable method to''' '''distinguish between [[Cancer|neoplastic]] and''' '''[[Neoplasm|non-neoplastic]] lesions''', hence every patient should undergo [[surgery]], appendectomy and [[Histopathology|histopathologic]] evaluation of the lesion
 
<nowiki>*</nowiki>'''Abbreviations:''' RLQ: Right Lower Quadrant, [[Alpha-fetoprotein|AFP]]: [[Alpha-fetoprotein]], [[Human chorionic gonadotropin|HCG: Human chorionic gonadotropin]], [[Lactate dehydrogenase|LDH: Lactate Dehydrogenase]], [[Carcinoembryonic antigen|CEA: Carcinoembryonic antigen]], [[CA-125|CA-125: Cancer antigen 125]], [[5-Hydroxyindoleacetic acid|5-HIAA: Urinary 5-hydroxyindoleacetic acid]] , [[Chromogranin A|CgA: Serum Chromogranin A]] ,PU: Periumbelical, TR: [[Tricuspid regurgitation]]


==References==
==References==
{{Reflist|2}}
{{Reflist|2}}
[[Category:Surgery]]
[[Category:Medicine]]
[[Category:Emergency medicine]]
[[Category:Oncology]]
[[Category:Up-To-Date]]
[[Category:Differential diagnosis]]

Latest revision as of 13:26, 15 July 2019


Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Soroush Seifirad, M.D.[2]

Overview

Appendix cancer must be differentiated from benign appendix lesions (mucocele, acute appendicitis), colorectal cancers, adenexal masses (ovarian tumors), and carcinoid tumors of the other organs.

Differentiating appendix cancer from other Diseases

Diseases Clinical manifestations Para-clinical findings
Symptoms Physical examination
Lab Findings Imaging Histo-

pathology

Abdo-
minal
pain
Change in girdle size Bowel

freq-

uency

Other

symptoms

Abdo-
minal
mass
Abdo-
minal
tender-
ness
Other

physical

exami-

nation

findings

5-HIAA
and/or
CgA
Other lab findings CT scan MRI Utra-

sounography

Other

diagnostic

studies

and

imaging

modalities

Appendix cancer Adeno-

carcinoma1

+/- -/+ <math>\downarrow</math> - - -
  • Soft
    tissue
    thickening
  • Wall
    irregularity
  • Presence
    of
    pseudo-
    myxoma
    peritonei
  • Calcification
  • Internal
    septations
  • Peri
    appendiceal
    fat
    stranding
    and
    intra-
    peritoneal
    free fluid
    which is a
    nonspecific
    finding
  • Cystic
    lesion
  • Diffusion
    weighted
    MRI
    has
    been
    shown to
    be
    the
    modality
    of choice
    for
    peritoneal
    carcino-
    matosis
  • Increased
    fluid
    signal on
    T2 weighted sequence
  • Soft
    tissue
    mass in
    the
    appendix
  • Invasion to
    the other
    structures
  • Dilated
    appendix
  • Peri-
    appendiceal
    fluid
    collection
  • Distinct
    appendix
    wall
    layers
Positron
emission
tomography

(PET)
Gross
pathology
:
  • Gray/yellow
    color
  • Cystic
    structures
    with
    angiolymphatic
    invasion
  • Appendix
    might be
    buried
    within
    the mass

Microscopic
pathology:

IHC:

  • MUC 2
  • MUC5AC
  • CK 8/18
  • CK 13
  • CK 19
  • CK 20
Carcinoid

tumor2

+/- - <math>\uparrow</math> - - +

Ki67:
a reliable
marker of
cell
proliferation

Gross
pathology
:
  • Prevalent
    at the
    tip of
    appendix
  • Generally
    less than
    1 cm
  • Gray or
    yellow
  • Well-
    demarcated
    firm
  • Intramural
    nodules
    that may
    narrow or
    obliterate
    appendiceal
    lumen
  • Proximal
    tumors
    may cause
    obstruction
    and
    appendicitis

Microscopic
pathology:

  • Insular
    growth
    pattern
    of solid
    islands of
    uniform
    polygonal
    cells with
    minimal
    pleomorphism
  • Retraction
    of
    peripheral
    tumor
    cells from
    stroma
  • Angio-
    lymphatic
    invasion
    is common
  • Granular
    eosinophilic
    cytoplasm
    with either
    diffusely
    scattered
    or
    peripherally
    clumped
    granules
  • Two types
    of well
    differentiated
    tumors:
    EC cell
    (serotonin
    producing)
    and rarely
    L-cell
    (enteroglucagon
    or
    peptide YY
    producing)

IHC:

  • Might be
    positive for
    S100
Goblet

cell

carcinoid

+ +/- <math>\uparrow</math> +/- +
  • Ascites
  • Shifting
    dullness
  • May
    appear
    anemic
+/- Unfortunately,
compared to the other carcinoid tumors of appendix,
GCC is more aggressive and
patients with GCC generally present at higher stages.
Hence, in addition to
the above mentioned
general findings for appendix cancers,
imaging studies should
look for evidences of peritoneal involvement,
bone metastasis, lymphadenopathy,
and metastatic lesions
in ovaries and/or prostate.

Gross
pathology
:

  • No gross
    tumor might
    be present
  • Thickened
    appendiceal
    wall

Microscopic
appearance:

  • GCC Generally
    spares mucosa
    and
    infiltrates
    muscularis
    propria
    and
    peri-
    appendiceal
    fat
  • Tumor
    cell clusters
  • Crypt-like
    structures
  • Tubules of
    mucus-secreting
    cells distended
    with mucin
    resembling
    goblet cells
  • Eosinophilic
    cytoplasm
    resembling
    carcinoid
    tumors
  • Pools of
    extracellular
    mucin
  • Scattered
    Paneth cells
    in tumors
    with crypt
    like
    structures
  • Extensive
    perineural
    invasion
  • Carcinomatous
    growth
    pattern:
  • Cribriform
    growth
    pattern,
    solid
    sheets of
    infiltrating
    signet ring
    cells
  • Nuclear
    pleomorphism
  • Increased
    mitotic
    activity
Diseases Abdo-
minal
pain
Change in girdle size Bowel

freq-

uency

Other

symptoms

Abdo-
minal
mass
Abdo-
minal
tender-
ness
Other

physical

exami-

nation

findings

5-HIAA
and/or
CgA
Other lab findings CT scan MRI Utra-

sounography

Other

diagnostic

studies

and

imaging

modalities

Histo-

pathology

Appendix Mucocele Mucosal

hyperplasia

- - -
  • Generally asympto-
    matic
  • Benign
    even
    after
    rupture
- +/- N/A - N/A
  • low
    attenuation
    well
    defined
    mass in
    RLQ
    near
    cecum
  • Inflammation
    is the key to
    distinguish
    between
    appendicitis
    and
    mucocele
  • Wall
    thickness
    does not
    distinguish
    between
    malignant
    and
    benign
    mucocele
  • Intramural
    nodule
    is a sign of
    neoplastic
    lesions. 4
Rounded
right iliac
fossa mass
  • T1: The
    signal
    depends
    on
    the mucin
    concen-
    tration,
    may be
    from
    hypointense
    to
    isointense
  • T2:
    Hyperintense
  • Histo-
    logically
    benign
  • Dilated
    fluid
    filled
    appendix
    in the
    RLQ.
  • Thin
    appendiceal
    wall
  • A focus
    of
    hyper-
    echogenicity
  • Since
    generally
    there is
    no inflammation
  • Surrounding
    fat
    is normal.
  • No peri-
    appendiceal
    fluid or
    collection
N/A Similar
to
hyperplastic
colon
polyp
Simple

or

retention

cyst

- - - - +/- - - N/A Degenerative
epithelial
changes
because of
obstruction
Mucinous cyst-

adenomas

+/- +/- <math>\uparrow</math><math>\downarrow</math>
  • Generally asympto-
    matic
  • Rupture
    may
    lead
    to
    Pseudo-
    myxoma
    peritonei
+/- +/- If develop

pseudo-
myxoma
peritonei
:

-
  • Histo-
    logically
    benign
  • Similar
    to
    colon
    adenomatous
    polyps or
    villous
    adnomas
Mucinous cystadeno-

carcinomas

+/- +/- <math>\uparrow</math><math>\downarrow</math> +/- +/- - -
  • Glandular
    invasion
    into the
    stoma
  • Pseudo-
    myxoma
    peritonei
Diseases Abdo-
minal
pain
Change in girdle size Bowel
freq-
uency
Other

symptoms

Abdo-
minal
mass
Abdo-
minal
tender-
ness
Other

physical
exami-
nation
findings

5-HIAA
and/or
CgA
Other lab findings CT scan MRI Utra-
sounography
Other
diagnostic
studies
and
imaging
modalities
Histo-

pathology

Ovarian cancer +/- +/- +/-<math>\downarrow</math> + +/- -
  • Adnexal
    mass
  • Adenexal
    Cyst
    (simple
    or
    complex)
  • Fluid
    accumulation
  • Endometrial
    thickening
  • Calcification
  • Pleural
    effusion
  • Peritoneal
    involvement
  • Lympha-denopathy
  • Adnexal
    mass
  • Adenexal
    cyst
    (simple
    or
    complex)
  • Except for
    Thecoma,
    ovarian
    masses
    are
    generally hyperintense
    on T1 and
    hypo or
    sointense
    on
    T2 imaging
  • Fluid
    accumulation
  • Endometrial
    thickening
  • Calcification
  • Pleural
    effusion
  • Peritoneal
    involvement
  • Lympha-
    denopathy
  • Adnexal
    mass
  • Adenexal
    cyst
    (simple
    or
    complex)
  • Fluid
    accumulation
  • Increased
    Doppler
    flow
  • Endometrial
    thickening
  • Calcification
N/A Depends
on the
tumor type.
You may
find the
details
here.
Colorectal cancer +/- +/- <math>\uparrow</math><math>\downarrow</math> + +/- Colonoscopy

Adeno-

carcinoma

Carcinoids

-/+(Carcinoid tumors)
  • Tumor
    mass
    and
    the
    extension
    of
    tumor to
    other
    structures
Generally
not
recommended:
may
evaluate
liver metastasis
or presence
of fluid
in abdominal
cavity, but it is
neither
sensitive
nor
specific.
PET
scan
,
Endoscopy,
Colonoscopy,

Barium enema

  • Depends
    on the
    tumor
    type.
    You will
    find more
    information
    here
Pseudomyxoma

peritonei

+ + <math>\uparrow</math><math>\downarrow</math> Bloating - + Ascites

Shifting dullness

-
  • Nonspecific
  • Depends
    on the
    etiology
    of the
    disease
  • Low-
    attenuation
    Scalloping
    of the
    visceral
    surfaces
    differentiates
    pseudo-
    myxoma

    from other
    causes of
    peritonitis.
  • Typically
    does not
    invade
    visceral
    organs
    or spread
    by lymphatic
    or
    hemato-
    genous
    routes
    unlike
    mucinous
    carcino-
    matosis

Charact-
erized
by a mass
which is
hypointense
on
T1-weighted
MRI
and
hyperintense
on
T2-weighted
MRI.
MRI has
better
sensitivity
in
detecting
ascites
fluid
and
mucocele.

  • The echoes
    within
    pseudo-
    myxoma
    peritonei

    are not
    mobile.
  • Echogenic
    septations
    within
    the
    gelatinous
    ascites.
  • Scalloping
    of the
    hepatic
    and
    splenic
    margins
18F-FDG
PET scan
  • Depending
    on
    WHO
    classification,
    whether it is
    low or high
    grade
    with
    cellular atypia
    or acellular mucin.
    ( DPAM, PMCA)
  • Gelatinous
    ascites
    in peritoneum
    and
    visceral
    organs,
    usually
    underneath
    the right
    hemidiaphragm,
    liver.
  • Omental cake

IHC:

Carcinoid syndrome -/+ - <math>\uparrow</math> - - + Depends
on the
tumor
type:
Depends on the
primary tumor location and type
  • Salt
    and
    pepper
    nuclei
  • Cellular
    uniformity
  • Central
    ovoid
    nucleus
  • Presence of
    ribbons,
    trabeculae,
    nesting,
    glands,
    gyriform,
    pseudorosettes
  • Insulinoma
    (Amyloid
    deposition)
  • Somatostatinom
    (Psammoma
    bodies)
  • Hyaline
    globules

IHC:

  • Synaptophysin
    (almost
    always,
    strongly
    and
    diffusely
    expressed )
  • CGA
  • CD56 and PGP
    ( less
    specific)
  • PDX1
  • ISL1
Appendicitis 3 PU,
RLQ
- <math>\uparrow</math><math>\downarrow</math> Nausea
&
vomiting
,
decreased

appetite

+/- + -
  • Appendiceal
    wall
    thickening
    /perforation
  • Peri-
    appendiceal
    inflammation,
    fluid
    accumulation,
  • Fat
    stranding
Increased
fluid
signal
on T2
weighted
sequence
Evidences
of
inflammation
  • Dilated
    appendix
  • Peri-
    appendiceal
    fluid
    collection
  • Distinct
    appendix
    wall
    layers
Tc-99m
labeled
anti-
CD15
antibodies
Evidences
of
inflammation
Diseases Abdo-
minal
pain
Change in girdle size Bowel

frequ- f ency

Other

symptoms

Abdo-
minal
mass
Abdo-
minal
tender-
ness
Other

physical

exami-

nation

findings

5-HIAA
and/or
CgA
Other lab findings CT scan MRI Utra-

sounography

Other

diagnostic

studies

and

imaging

modalities

Histo-

pathology

1 Adenocarcinomas usually present with appendicitis, barely they might present with Pseudomyxoma peritonei; meanwhile pseudomyxoma peritonei is more prevalent in perforated mucocele, goblet cell tumor or high stages of adenocarcinoma.

2 Generally appendix carcinoids are asymptomatic, they were only become symptomatic if they metastasize to the liver, or in rare cases make an obstruction and present with appendicitis which is quit uncommon in appendiceal carcinoids compared to appendiceal adenocarcinoma. Any patient with carcinoid syndrome should be evaluated for appendix carcinoids.

3 Every patient with appendicitis should be evaluated for appendix cancer, 0.5 in 100 appendicitis cases are because of appendix cancer.

4 Imaging is not a reliable method to distinguish between neoplastic and non-neoplastic lesions, hence every patient should undergo surgery, appendectomy and histopathologic evaluation of the lesion

*Abbreviations: RLQ: Right Lower Quadrant, AFP: Alpha-fetoprotein, HCG: Human chorionic gonadotropin, LDH: Lactate Dehydrogenase, CEA: Carcinoembryonic antigen, CA-125: Cancer antigen 125, 5-HIAA: Urinary 5-hydroxyindoleacetic acid , CgA: Serum Chromogranin A ,PU: Periumbelical, TR: Tricuspid regurgitation

References